Clinical trials
Vaginitis clinical trials
Below are recruiting vaginitis clinical trials, each written for real people, not researchers. We’re tracking 243 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07218016Recruiting
Recovery After Prolapse Surgery Study
This study tracks how well women recover after surgery for advanced pelvic organ prolapse. You will wear a small activity monitor before and after surgery to see how your activity level changes, and you'll follow a simple exercise plan to help your recovery.
San Diego, CaliforniaAges 18–99 - NCT07544680Recruiting
Vaginal fluid test study for endometrial cancer detection
This study tests whether a simple vaginal fluid sample can help detect endometrial cancer (cancer of the uterus lining) or precancerous changes. You'll provide a vaginal specimen alongside your standard medical care, helping researchers develop a non-invasive screening tool.
Sarasota, FloridaAges 18 years+ - NCT07124000Recruiting
T-DXd for advanced HER2-positive solid tumors
This trial is for people with advanced HER2-positive solid tumors (cancers that cannot be removed by surgery or have spread). It tests the drug T-DXd (also called Enhertu) when your doctor has already decided it's the right treatment for you and you have no other good options.
Birmingham, AlabamaAges 18–130 - NCT05256225RecruitingPhase 3
Adding Herceptin medicines to chemo for HER2-positive endometrial cancer
This Phase 3 trial tests whether adding Herceptin Hylecta or Phesgo to standard chemotherapy works better than chemotherapy alone for HER2-positive serous endometrial cancer or carcinosarcoma. It may help by improving how well treatment controls or shrinks the cancer.
Birmingham, AlabamaAges 18 years+ - NCT07714902Recruiting
Calcium gluconate to reduce bleeding during vaginal birth
This study tests if giving calcium gluconate during childbirth can reduce blood loss. It might help women having a vaginal delivery after 37 weeks of pregnancy.
HaifaAges 18 years+ - NCT06810739Recruiting
Women's Screening and Self-Testing Program (PROMETA)
This study tests a self-screening program for cervical cancer among women who are already receiving HIV care. It aims to make screening easier and more accessible.
MaputoAges 25–49 - NCT02993900Recruiting
Brachytherapy guided by imaging for gynecologic cancers
This study tests image-guided internal radiation (brachytherapy) for certain gynecologic cancers. It may help deliver radiation more precisely by using scans done close to enrollment.
Baltimore, MarylandAges 18–100 - NCT03617133RecruitingPhase 2
MRI-guided radiation plus chemo for cervical cancer
This trial tests a more precise way to deliver radiation for locally advanced cervical cancer using MRI guidance during treatment, along with chemotherapy. It may help shrink tumors more effectively while aiming to reduce side effects by targeting the right areas.
ViennaAges 18–99 - NCT05444504Recruiting
Test a small device to help treat vaginal fistula
This study looks at whether “insertable cups” are helpful and acceptable for treating obstetric vaginal fistula (a hole between the birth canal and urinary tract). The trial checks if the device can close the problem and whether participants feel it’s safe and practical to use.
MankessimAges 15 years+ - NCT04094454Recruiting
Vaginal dilation during pelvic radiation for anal cancer
This trial studies a method to make vaginal dilation easier during pelvic radiotherapy in women with anal cancer. It may help reduce or prevent treatment-related vaginal narrowing and improve comfort and function.
HeidelbergAges 18 years+ - NCT04305808Recruiting
Study of gut, bladder, and vaginal bacteria in recurrent UTIs
This study looks at the bacteria living in the vagina, urine tract, and stool to learn why some women get repeated urinary tract infections (UTIs). The results may help doctors better prevent or treat UTIs in the future.
Jerusalem, JerusalemAges Any age - NCT04422366RecruitingPhase 3
9-valent HPV vaccine study for healthy Chinese women
This trial tests a 9-type HPV vaccine to see how well it works, how it helps the body build protection, and whether it’s safe. It’s for healthy Chinese women who have not had HPV vaccination before and meet specific health and timing requirements.
Liuzhou, GuangxiAges 20–45 - NCT04807842Recruiting
Testing ActiGel Plus to treat bacterial vaginosis
This study tests whether ActiGel Plus can treat bacterial vaginosis (BV). It may help by improving symptoms and vaginal health after BV is confirmed.
HamburgAges 18 years+ - NCT05027776RecruitingPhase 3
HPV vaccine study for healthy girls and young women
This trial studies whether a quadrivalent HPV vaccine is safe and helps the body build protection (immunity) against HPV. It enrolls healthy Chinese females who are not already treated for HPV-related infection.
Mianyang, SichuanAges 9–26 - NCT05051722Recruiting
Test DNA blood and tissue markers to detect gynecologic cancers
This study looks for “methylated DNA markers” (special DNA patterns) to help detect endometrial, ovarian, and cervical cancers, and to support doctors around planned procedures. It may help find cancer earlier or better sort out who needs closer treatment.
Phoenix, ArizonaAges 18 years+ - NCT05127252Recruiting
Study how gut bacteria may affect time to pregnancy
This study looks at whether differences in the gut (microbiome) are linked to how long it takes to get pregnant and pregnancy outcomes. It may help researchers understand who might benefit from future microbiome-focused approaches.
Stockholm, HuddingeAges 18–40 - NCT05179447Recruiting
Study testing added treatment after endometrial cancer surgery
This trial looks at how to guide follow-up (adjuvant) treatment after surgery for certain early-stage, higher-risk endometrial cancer. It may help by tailoring care based on patient and tumor details to lower the chance of the cancer coming back.
Wuhan, HubeiAges 18–75 - NCT05242861Recruiting
Reviewing outcomes after brachytherapy for women’s cancers
This study looks back at medical records to understand results after brachytherapy (a form of cancer radiation delivered from inside or close to the tumor) in women with gynecologic cancer. It may help doctors improve future treatment decisions, but you would not have to receive an experimental treatment.
Hangzhou, ZhejiangAges 18–80 - NCT05244967Recruiting
Study of sexually transmitted infections and female fertility impact
This study looks at how sexually transmitted infections affect female fertility. It mainly enrolls young adults to better understand patterns and outcomes over time.
LübeckAges 18–22 - NCT05255289Recruiting
Midurethral sling surgery for stress urine leakage
This trial studies how safe and effective a midurethral sling operation is for people with stress urinary incontinence (urine leakage with coughing, laughing, or exercise). It also requires special bladder testing before and after surgery to measure results.
New Taipei CityAges 30–100 - NCT05255653RecruitingPhase 2/Phase 3
Personalized after-surgery treatment for endometrial cancer by tumor type
This trial studies which after-surgery (adjuvant) treatment works best when endometrial cancer is classified by specific tumor DNA/molecular features. You may be offered treatment based on the tumor results, aiming to improve outcomes and lower the risk of the cancer coming back.
TorontoAges 18 years+ - NCT05371353Recruiting
Study of how long HPV vaccine immunity lasts
This study checks how well the HPV (cancer-preventing) vaccine protection stays in your body over time. It may help confirm the vaccine’s “long-lasting” immune response and guide future vaccination confidence.
Yangchun, GuangdongAges 9–45 - NCT05473273Recruiting
Blood test study during normal frozen embryo transfer
This study measures changes in your blood immune markers during frozen embryo transfer when the embryo is chromosomally normal. It may help clinics understand what blood immune patterns relate to successful pregnancy in natural or hormone-prepared cycles.
Abu Dhabi, Abu Dhabi EmirateAges 18–40 - NCT05586334Recruiting
Test a device to help predict preterm birth risk
This trial tests an innovative device that measures risk of preterm birth in pregnant people who come to the emergency room early in pregnancy with signs that labor might start. It may help doctors identify who needs closer monitoring or treatment sooner.
ColombesAges 18 years+
Hear when a new Vaginitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for vaginitis?
- Yes. Clin2 currently lists 243 recruiting vaginitis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a vaginitis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a vaginitis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.